+ All Categories
Home > Documents > Pharmacology of Drugs for Anemia

Pharmacology of Drugs for Anemia

Date post: 14-Apr-2018
Category:
Upload: teus-fatamorgana
View: 218 times
Download: 0 times
Share this document with a friend

of 49

Transcript
  • 7/30/2019 Pharmacology of Drugs for Anemia

    1/49

    PHARMACOLOGY OF DRUGS FOR

    ANEMIA

    Dr.Datten Bangun MSc.SpFK

    Dept.Farmakologi & TherapetikFak.Kedokteran UHN

    M E D A N

  • 7/30/2019 Pharmacology of Drugs for Anemia

    2/49

    ANEMIA

    Anemia can be defined as a reduction in the

    hemoglobin,hematocrit or red cell number.

    In physiologic terms an anemia is any disorder

    in which the patient suffers from tissue

    hypoxia due to decreased oxygen carryingcapacity of the blood

  • 7/30/2019 Pharmacology of Drugs for Anemia

    3/49

    Hematinics

    These are drugs used to treat anemia

    IronVitamin B12, Cyanocobalamin

    Folic acid

    Erythropoietin

  • 7/30/2019 Pharmacology of Drugs for Anemia

    4/49

    4

    TYPES OF ANEMIA

    Various classifications:Examples:

    Iron deficiency anemia ----

    microcytic , hypochromicMegaloblastic anemia ----

    macrocytic , normochromic

    due to Vit. B12 or Folic Acid deficiency

    Anemia due to decreased Erythropoietin

    as in chronic renal failure

  • 7/30/2019 Pharmacology of Drugs for Anemia

    5/49

    Causes of Anemia

    1. Diminished production and or

    replacement of red blood cells.

    2. Excessive breakdown and loss of red

    blood cells.

    Hemodilution while not a cause of anemia, it

    does cause an anemia-like effect.

  • 7/30/2019 Pharmacology of Drugs for Anemia

    6/49

    1. Diminished Production/Replacement of

    RBCs Anemia's

    Microcytic anemia deficiency of Fe RBCs appear pale and smaller, and we see more reticulocytes

    in circulation.

    Can be caused by the chronic use of aspirin, which irritatesthe stomach GI blood loss.

    Normocytic anemia deficiency of Erythropoietin Caused by compromised renal function.

    Macrocytic Anemia- deficiency of folic acid and B12 Diminished cell division and release of larger cells in

    circulation.

  • 7/30/2019 Pharmacology of Drugs for Anemia

    7/49

    2. Breakdown of RBCs Anemia

    Bleeding: can be due to an ulcer or in females bloodloss due to their menstrual cycle

    Use of drugs that irritate the GI tract (aspirin)

    Hemolysis (Hemolytic Anemia) can be caused by:

    Autoimmune disease

    Mechanical (heart valves, microvascular disease)

    Toxins (e.g., snake venom)

  • 7/30/2019 Pharmacology of Drugs for Anemia

    8/49

    Anti anaemic Drugs

    Haematopoiesis: it is the production of

    erythrocytes, platelets, and leukocytes from

    undifferentiated stem cells.

    The haematopoietic machinary reside in the

    bone marrow in adults.

    It requires a constant supply of essential

    nutrients iron, vit B12, folic acid and

    presence of hematopoietic growth factors

  • 7/30/2019 Pharmacology of Drugs for Anemia

    9/49

    9

    ANTI-ANEMIC DRUGS

    Drugs effective in iron deficiency and otherhypochromic anemias:

    Iron

    Pyridoxine , Riboflavin , CopperDrugs effective in megaloblastic anemia:

    Vitamin B12

    Folic Acid

    Hematopoietic growth factors:

    Erythropoietin

  • 7/30/2019 Pharmacology of Drugs for Anemia

    10/49

    IRON FACTS

    All body cells need iron. It is crucial for oxygen

    transport, energy production, and cellular growth

    and proliferation.

    The human body contains an average of 3.5 g of

    iron (males 4 g, females 3 g).

    The typical daily normal diet contains 10

    20 mg ofiron.

    Only about 10% of dietary iron is absorbed (12 mg/day).

  • 7/30/2019 Pharmacology of Drugs for Anemia

    11/49

    Anti anaemic Drugs

    Iron: Total quantity of iron in the body is 4-5G,

    65-70% in the form of Hb in RBC, 4% in

    myoglobin, 1% in various heme compound,

    15-30% stored in the form of ferritin and

    hemosiderin in RE system, liver, spleen,

    intestinal mucosa and bone marrow

  • 7/30/2019 Pharmacology of Drugs for Anemia

    12/49

    12

    IRON

    Preparations:Oral:

    Ferrous sulphate

    Ferrous gluconateFerrous fumarate , etc.

    Parenteral:

    Iron dextran ---- i.m or i.v

    Iron Sorbitol ----- i.m only.

  • 7/30/2019 Pharmacology of Drugs for Anemia

    13/49

    13

    Pharmacokinetics

    Absorption ---- depends on

    requirements

    iron stores

    Ferrous (Fe++) / ferric (Fe+++) form

    pH

    Vitamin C Chelators or complexing agents

    Malabsorption syndrome

  • 7/30/2019 Pharmacology of Drugs for Anemia

    14/49

    Iron transport

    Most absorbed iron is transported in thebloodstream bound to the glycoprotein

    transferrin.

    Transferrin is a carrier protein that plays a

    role in regulating the transport of iron from

    the site of absorption to virtually all tissues.

    Transferrin binds only two iron atoms.

    Normally, 2045% of transferrin binding sites

    are filled (measured as percent transferrin

    saturation [TS]).

  • 7/30/2019 Pharmacology of Drugs for Anemia

    15/49

    Iron transport

  • 7/30/2019 Pharmacology of Drugs for Anemia

    16/49

    Ferritin molecules storethousands of iron atoms

    within their mineral core.

    When excess dietary iron is

    absorbed, the body

    responds by producing

    more ferritin to facilitate

    iron storage.

  • 7/30/2019 Pharmacology of Drugs for Anemia

    17/49

    Importance of Iron

    Iron forms the nucleus of the iron-porphyrin heme ring,

    This with globin chains forms hemoglobin.

    Function of Haemoglobin:

    Reversibly binds oxygen and provides the critical

    Mechanism for oxygen delivery from the lungs to other

    tissues.

    In the absence of adequate iron, small erythrocytes

    with insufficient hemoglobin are formed, giving rise to

    Microcytic hypochromic anemia

  • 7/30/2019 Pharmacology of Drugs for Anemia

    18/49

    18

    Acute Oral toxicity (overdose ; poisoning)

    Necrotizing gastroenteritis with ----

    vomiting, abdominal pain, bloody diarrhea

    Shock , lethargy & dyspnea

    Severe metabolic acidosis

    Coma

    Death

    A O l i i ( d i i )

  • 7/30/2019 Pharmacology of Drugs for Anemia

    19/49

    19

    Acute Oral toxicity (overdose ; poisoning):

    (Contd.)

    Treatment:Whole bowel irrigation

    Desferrioxamine (Deferoxamine)

    orally --- for Unabsorbed iron Parenteral ( i.m. , i.v. ) --- for iron absorbed

    Desferrioxamine + ferric iron

    Ferrioxamine --- excreted in urine and bile.

  • 7/30/2019 Pharmacology of Drugs for Anemia

    20/49

    20

    Chronic iron toxicity (iron overload): (Contd.)

    Hemosiderosis:

    a focal or general increase in tissue iron stores

    without associated tissue damage

    Hemochromatosis:

    associated with tissue damage

    h i i i i (i l d)

  • 7/30/2019 Pharmacology of Drugs for Anemia

    21/49

    21

    Chronic iron toxicity (iron overload)

    (Contd.)

    Treatment:

    IntermittentVenesection(Phlebotomy)----

    when there is no anemia

    Chelation (Desferrioxamine) ----

    for transfusional overload

  • 7/30/2019 Pharmacology of Drugs for Anemia

    22/49

    22

    Adverse effects of Parenteral iron therapy

    Local pain & tissue staining

    (browndiscoloration of tissue overlying the injection

    site).

    Headache , light-headedness , fever , arthralgias,

    nausea , vomiting , back pain , flushing ,

    urticaria, bronchospasm , & ,

    Rarely anaphylaxis & death

  • 7/30/2019 Pharmacology of Drugs for Anemia

    23/49

    23

    VITAMIN B12

    Chemistry

    Porphyrin-like ring with a central cobalt atom

    & nucleotide.

    Cobalamins = various organic groups covalentlybound to cobalt atom

    Cyanocobalamine hydroxycobalamin & other

    cobalamins (found in food sources) are convertedto active forms Deoxyadenosylcobalamin

    &methylcobalamin

  • 7/30/2019 Pharmacology of Drugs for Anemia

    24/49

    24

    Active forms of vitamin B12 in human:

    Deoxyadenosylcobalamin

    Methylcobalamin

    Vitamin B12 available for therapeutic uses:

    Cyanocobalamin

    Hydroxycobalamin

    Hydroxycobalamin --- is preferred becauseit is highly protein-bound & therefore

    remains longer in the circulation.

    Ph ki ti

  • 7/30/2019 Pharmacology of Drugs for Anemia

    25/49

    25

    Pharmacokinetics

    Absorption:

    Intrinsic factor (IF) --- a glycoprotein ,secreted by parietal cells of gastric mucosa

    IF-Vit.B12 Complex --- absorbed by

    active transport in the distal ileum

    Transported in plasma bound to the

    glycoprotein transcobalamin II &

    is taken up by tissues where required &

    stored in hepatocytes

    Pharmacokinetics (Contd )

  • 7/30/2019 Pharmacology of Drugs for Anemia

    26/49

    26

    Pharmacokinetics (Contd.)

    Route of administration

    Mostly ------ Parenteral ---- i.m.

    Oral

    Aerosol

    Pharmacokinetics (Contd )

  • 7/30/2019 Pharmacology of Drugs for Anemia

    27/49

    27

    Pharmacokinetics (Contd.)

    Elimination:

    not significantly metabolized

    pass into bile

    Enterohepatic circulation

    Excreted via kidney

    Features of Vitamin B12 deficiency

  • 7/30/2019 Pharmacology of Drugs for Anemia

    28/49

    28

    Features of Vitamin B12 deficiency

    Impairment of DNA synthesis

    affects all cells but most apparently RBCs.

    Megaloblastic Anemia

    GI symptoms

    neurologic abnormalities

  • 7/30/2019 Pharmacology of Drugs for Anemia

    29/49

    29

    Features Vitamin B12 deficiency (Contd.)

    Neurological abnormalities :

    Degeneration of brain and spinal cord (Subacute

    combined degeneration ) and peripheral nerves.

    Symptoms may be psychiatric & physical.Paresthesia & weakness in peripheral nerves

    spasticity, ataxia, & other CNS dysfunction

  • 7/30/2019 Pharmacology of Drugs for Anemia

    30/49

    30

    Uses

    Pernicious (addisonian) anemia

    After partial or total gastrectomy

    Malabsorption syndromes

    Insufficient dietary intake

    Hydroxycobalamin (Not cyanocobalamin)

    Tobacco Amblyopia

    Cyanide toxicity

    d ff

  • 7/30/2019 Pharmacology of Drugs for Anemia

    31/49

    31

    Adverse effects

    Allergic hypersensitivity reactionsAntibodies to hydroxycobalamin-transcobalamin

    II complex

    Arrhythmias secondary to hypokalemia

  • 7/30/2019 Pharmacology of Drugs for Anemia

    32/49

    32

    FOLIC ACID (PTEROYLGLUTAMIC ACID; VITAMIN B9)

    Is inactive Active form is ---- tetrahydrofolic acid

  • 7/30/2019 Pharmacology of Drugs for Anemia

    33/49

    33

    Pharmacokinetics

    Route of administration ----- usually oral

    In diet ---- Polyglutamate form

    For absorption ---- must be converted to ---Mono-glutamyl form

    Absorbed mostly --- in proximal jejunum

  • 7/30/2019 Pharmacology of Drugs for Anemia

    34/49

    34

    Functions

    Is required for synthesis of Amino acids ,

    purines, pyrimidines, & DNA ; &

    therefore in the cell division

  • 7/30/2019 Pharmacology of Drugs for Anemia

    35/49

    35

    Features of folic acid deficiency

    Mitotically active tissues such as

    erythroid tissues are markedly affected.

    Anemia

    Congenital malformations ---

    neural tube defects ( e.g., spina bifida)

    Vascular disease

  • 7/30/2019 Pharmacology of Drugs for Anemia

    36/49

    36

    Vitamin C

    Vitamin C deficiency can cause megaloblastic anemia

  • 7/30/2019 Pharmacology of Drugs for Anemia

    37/49

    37

    Uses

    Prevention & treatment of folic acid deficiency

    Dietary insufficiency (e.g. in elderly)

    Pregnancy & lactation

    to prevent --- Congenital malformations ---neural tube defects ( e.g., spina bifida)

    High red cell turn over --- e.g. in

    hemolytic anemias ---

    Premature infants

    Malabsorption syndromes

    Uses (contd )

  • 7/30/2019 Pharmacology of Drugs for Anemia

    38/49

    38

    Uses (contd.)

    Drugs

    Antiepileptics ---- enzyme inducers

    Phenytoin

    Primidone

    Phenobarbitone

    Antimalarials

    pyrimethamine

    Methotrexate

    FOLINIC ACID (not folic acid)

  • 7/30/2019 Pharmacology of Drugs for Anemia

    39/49

    39

    Uses (contd.)

    Myelofibrosis

    Exfoliative dermatitis

    Rheumatoid arthritis

    Malignant disease , e.g., lymphoma Chronic hemodialysis

  • 7/30/2019 Pharmacology of Drugs for Anemia

    40/49

    40

    Adverse effects

    Generally well tolerated

    Rarely ---

    G.I. Disturbances

    hypersensitivity reactions Status epilepticus may be precipitated

  • 7/30/2019 Pharmacology of Drugs for Anemia

    41/49

    41

    ERYTHROPOIETIN (EPOTEIN)

    a glycoprotein hormone

    produced :

    90% --- by peritubular cells in kidney

    remainder --- by liver and other tissues is essential for normal reticulocyte production

    synthesis is stimulated by hypoxia

    synthesized for clinical use ---- by ---

    recombinant DNA technology

  • 7/30/2019 Pharmacology of Drugs for Anemia

    42/49

    42

    Pharmacokinetics

    Route of administration --- S.C. or I.V.

    Plasma t1/2 ---- 4 - 13 hrs in patients with

    chronic renal failure.

    Not cleared by dialysis

  • 7/30/2019 Pharmacology of Drugs for Anemia

    43/49

    43

    Mechanism of action

    increases rate of stem cell differentiation

    increases rate ofmitosis in red cell precursors,

    blast-forming units, colony forming cells.

    increases release ofreticulocyte from marrowincreases Hb synthesis

    its action requires adequate stores ofiron

    Uses

  • 7/30/2019 Pharmacology of Drugs for Anemia

    44/49

    44

    Uses

    Anemia associated with chronic renal failure

    premature infantsAnemia during chemotherapy ofcancer

    Anemia ofAIDS (which is exacerbated by

    zidovudine treatment)

    to increase the yield ofautologous blood before

    donation

    Anemia of chronic inflammatory conditions

    such as rheumatoid arthritis

    MISUSED --- by sports people

  • 7/30/2019 Pharmacology of Drugs for Anemia

    45/49

    45

    Adverse effects

    Usually due to excessive increase in hematocrit

    increase blood pressure

    thrombosis

    seizures

    headache

    hypertensive crises with encephalopathy-like

    symptoms

    clotting in dialyser

  • 7/30/2019 Pharmacology of Drugs for Anemia

    46/49

    46

    Adverse effects

    Transient influenza-like symptoms ------

    chills & myalgias

    iron deficiency

    transient increases in platelet count

    hyperkalemia

    skin rashes

    pure red cell aplasia --- discontinue the drug

    antibodies to epoetins

    / d

  • 7/30/2019 Pharmacology of Drugs for Anemia

    47/49

    47

    Precautions / contraindications

    hypertension should be well controlled

    seizures

    thrombocytosis

    ischemic vascular disease

    iron , folic acid , vit. B12 supplements may be

    needed

    heparin during dialysis

    i

  • 7/30/2019 Pharmacology of Drugs for Anemia

    48/49

    48

    Monitor

    hematocrit

    blood pressure

    platelet count

    serum potassium

  • 7/30/2019 Pharmacology of Drugs for Anemia

    49/49


Recommended